Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

ASCO news: Abgenix presents preclinical pharmacological profile of fully human anti-EGF MAb

May 26, 1999

Cancer vaccine induces disease stabilization and is well tolerated in ongoing early clinical trials

May 26, 1999

Joint effort at Zeneca and Isis results in preparation of TS mRNA-targeting ODNs

May 26, 1999

BPHA: a potent and selective MMP inhibitor in early development at Shionogi

May 26, 1999

C225 demonstrates high efficacy and good tolerance in two types of carcinomas

May 25, 1999

SkyePharma announces U.S. launch of DepoCyt

May 25, 1999

Corixa, Zambon collaborate to develop lung cancer immunotherapeutic vaccines

May 25, 1999

K1-5 is a more potent angiogenesis inhibitor than angiostatin

May 25, 1999

MMP inhibitor MMI-270 tested in cancer patients in combination with 5-FU/folinic acid

May 24, 1999

Compounds in development at Shionogi reverse oncogene-induced cell transformation

May 24, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Anti-C5aR1 antibodies linked to outcomes in giant cell arteritis
BioWorld Science
More effective glucocorticoid-sparing therapies are needed for the treatment of giant cell arteritis (GCA). Studies found that complement signaling pathways...
Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs
BioWorld Science
Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...